Ignite Creation Date:
2024-05-05 @ 11:11 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01276769
Status:
UNKNOWN
Last Update Posted:
2011-11-16
First Post:
2010-12-10
Brief Title:
Comparison Study of Neoadjuvant Paclitaxel Plus CarboplatinEpirubicin Treatment in Triple-negative Breast Cancer
Sponsor:
Chinese Academy of Medical Sciences
Organization:
ChineseAMS
Organization Data
Organization:
ChineseAMS
Class:
UNKNOWN
Study ID:
LC2010A03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chinese Academy of Medical Sciences
Lead Sponsor Class:
OTHER
Responsible Party:
ZHANG Pin
Responsible Party Title:
Medicine Oncology Department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Chinese Academy of Medical Sciences
Old Name:
None
Old Organization:
None